[["introduction-load-the-datasets.html", "Microbial Bile Acid Metabolism Shapes T Cell Responses During Inflammation Chapter 1 Introduction: load the datasets 1.1 Load packages 1.2 Load datasets", " Microbial Bile Acid Metabolism Shapes T Cell Responses During Inflammation Oriana Miltiadous 2023-08-10 Chapter 1 Introduction: load the datasets 1.1 Load packages library(janitor) library(readxl) library(tidyverse) library(ggpubr) library(data.table) 1.2 Load datasets #patient cohort cohort_BAS&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/cohort_BAS.csv&quot;) ursodiol&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/ursodiol.csv&quot;) #metabolomics data #concentrations conc_all_filtered&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/conc_all_filtered.csv&quot;) filtered_combined_table&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/filtered_combined_table.csv&quot;) #annotations ba_families&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/ba_families.csv&quot;) #16s data counts_samples &lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/counts_samples.csv&quot;) asv_annotation_blast_ag&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/asv_annotation_blast_ag.csv&quot;) asv_alpha_all&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/asv_alpha_all.csv&quot;) asv_annotation_blast_color_ag&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/asv_annotation_blast_color_ag.csv&quot;) #shotgun data BSH_metalphlan &lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/BSH_metalphlan.csv&quot;) bai_genes_clean&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/bai_genes_clean.csv&quot;) taxa_bas_later&lt;-read_csv(&quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/taxa_bas_later.csv&quot;) #ursodiol cohort: double check that it&#39;s ok to share patients_urso_CIF&lt;- read_csv( &quot;/Volumes/vandenbrinklab/Oriana/BAs_published_datasets/patients_urso_CIF.csv&quot;) categorize_bile_acids &lt;- function(df, ba_families){ df %&gt;% left_join(ba_families) %&gt;% mutate(primary_pool=ifelse(prim_vs_sec==&quot;Primary&quot;, value, 0)) %&gt;% mutate(secondary_pool=ifelse(prim_vs_sec==&quot;Secondary&quot;, value, 0)) %&gt;% mutate(sulfated_pool=ifelse(sulfated==&quot;Y&quot;, value, 0)) %&gt;% mutate(conjugated_pool=ifelse(amidated==&quot;Y&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(unconjugated_pool=ifelse(amidated==&quot;N&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(secondary_nonUDCA=ifelse(prim_vs_sec==&quot;Secondary&quot; &amp; udca==&quot;N&quot;, value, 0)) %&gt;% mutate(total_BAs=value) %&gt;% mutate(total_nonUDCA_pool=ifelse(udca==&quot;N&quot;, value, 0)) %&gt;% mutate(glycine_pool=ifelse(glycine==&quot;Y&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(taurine_pool=ifelse(taurine==&quot;Y&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(taurine_SBA_pool=ifelse(taurine==&quot;Y&quot; &amp; prim_vs_sec==&quot;Secondary&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(taurine_PBA_pool=ifelse(taurine==&quot;Y&quot; &amp; prim_vs_sec==&quot;Primary&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(glycine_SBA_pool=ifelse(glycine==&quot;Y&quot;&amp; prim_vs_sec==&quot;Secondary&quot; &amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% mutate(glycine_PBA_pool=ifelse(glycine==&quot;Y&quot; &amp;prim_vs_sec==&quot;Primary&quot;&amp; sulfated==&quot;N&quot;, value, 0)) %&gt;% select(-colnames(ba_families), -value) } "],["analyze-the-effect-of-udca-administration-on-the-bile-acid-pool-supplementary-figure-5.html", "Chapter 2 Analyze the effect of UDCA administration on the bile acid pool (supplementary figure 5) 2.1 Plot ursodiol exposure and secondary BAs concentrations 2.2 Plot correlation of ursodiol with other bile acid pools: plot conjugated UDCA (tauroursodeoxycholic_acid+glycoursodeoxycholic_acid), TBAs (total_BAs), PBAs (primary_pool), SBAs (secondary_pool), nonUDCA total BAs (total_nonUDCA_pool), nonUDCA SBAs (secondary_nonUDCA), secondary/primary ratio (SP_ratio) 2.3 Create correlation plots to evaluate association of UDCA with all individual BAs", " Chapter 2 Analyze the effect of UDCA administration on the bile acid pool (supplementary figure 5) #summarize bile acid pools both_conc&lt;- cohort_BAS %&gt;% select(-ursodiol)%&gt;% left_join(conc_all_filtered) %&gt;% clean_names() #prep dataset prepping each BA depending on its classifications both_conc_pools&lt;-both_conc %&gt;% gather(&quot;bile_acid&quot;, &quot;value&quot;, names(.)[8]:names(.)[ncol(.)]) %&gt;% select(-gi_gvhd, -later, -periengr) %&gt;% filter(bile_acid!=&quot;beta_muricholic_acid&quot;) %&gt;% #removing because it&#39;s not measured in all samples filter(bile_acid!=&quot;omega_muricholic_acid&quot;) %&gt;% #removing because it&#39;s not measured in all samples categorize_bile_acids(ba_families) both_conc_pools_final&lt;-both_conc_pools %&gt;% group_by(sampleid) %&gt;% summarise(across(where(is.numeric), sum)) %&gt;% left_join(ursodiol) #rearrange ursodiol both_conc_pools_final$ursodiol &lt;-factor(both_conc_pools_final$ursodiol, levels=c(&quot;Y&quot;,&quot;2-3w&quot;,&quot;3-4w&quot;,&quot;1-2m&quot;, &quot;N&quot;)) ##Evaluation of ursodiol exposure and UDCA concentration ursodiol_BAs&lt;-both_conc %&gt;% left_join(ursodiol) #rearrange ursodiol ursodiol_BAs$ursodiol &lt;-factor(ursodiol_BAs$ursodiol, levels=c(&quot;Y&quot;,&quot;2-3w&quot;,&quot;3-4w&quot;,&quot;1-2m&quot;, &quot;N&quot;)) ursodiol_BAs %&gt;% ggplot(aes(x=ursodiol, y=log10(`ursodeoxycholic_acid`), color=ursodiol)) + geom_boxplot(width=0.2, outlier.shape =NA, lwd=.7)+ geom_jitter(width=0.2, alpha=0.2)+ theme_classic() + xlab(&quot;ursodiol exposure&quot;)+ stat_compare_means(comparisons=list( c(&quot;Y&quot;, &quot;2-3w&quot;),c(&quot;3-4w&quot;, &quot;Y&quot;), c(&quot;Y&quot;, &quot;1-2m&quot;), c(&quot;N&quot;, &quot;Y&quot;), c(&quot;3-4w&quot;, &quot;2-3w&quot;),c(&quot;1-2m&quot;, &quot;2-3w&quot;), c(&quot;N&quot;, &quot;2-3w&quot;), c(&quot;1-2m&quot;, &quot;3-4w&quot;), c(&quot;N&quot;, &quot;3-4w&quot;), c(&quot;N&quot;, &quot;1-2m&quot;) ), #label=&quot;p.signif&quot;, method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;#a6611a&quot;, &quot;#bf812d&quot;,&quot;#dfc27d&quot;, &quot;#80cdc1&quot;, &quot;#018571&quot;))+ theme(legend.position=&quot;none&quot;) 2.1 Plot ursodiol exposure and secondary BAs concentrations both_conc_pools_final %&gt;% ggplot(aes(x=ursodiol, y=log10(secondary_pool), color=ursodiol)) + geom_boxplot(width=0.2, outlier.shape =NA, lwd=.7)+ geom_jitter(width=0.2, alpha=0.2)+ theme_classic() + xlab(&quot;ursodiol exposure&quot;)+ stat_compare_means(comparisons=list( c(&quot;Y&quot;, &quot;2-3w&quot;),c(&quot;3-4w&quot;, &quot;Y&quot;), c(&quot;Y&quot;, &quot;1-2m&quot;), c(&quot;N&quot;, &quot;Y&quot;), c(&quot;3-4w&quot;, &quot;2-3w&quot;),c(&quot;1-2m&quot;, &quot;2-3w&quot;), c(&quot;N&quot;, &quot;2-3w&quot;), c(&quot;1-2m&quot;, &quot;3-4w&quot;), c(&quot;N&quot;, &quot;3-4w&quot;), c(&quot;N&quot;, &quot;1-2m&quot;) ), #label=&quot;p.signif&quot;, method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;#a6611a&quot;, &quot;#bf812d&quot;,&quot;#dfc27d&quot;, &quot;#80cdc1&quot;, &quot;#018571&quot;))+ theme(legend.position=&quot;none&quot;) 2.2 Plot correlation of ursodiol with other bile acid pools: plot conjugated UDCA (tauroursodeoxycholic_acid+glycoursodeoxycholic_acid), TBAs (total_BAs), PBAs (primary_pool), SBAs (secondary_pool), nonUDCA total BAs (total_nonUDCA_pool), nonUDCA SBAs (secondary_nonUDCA), secondary/primary ratio (SP_ratio) both_conc_pools_final %&gt;% mutate(SP_ratio=secondary_pool/primary_pool) %&gt;% mutate(SP_ratio_nonUDCA=secondary_nonUDCA/primary_pool) %&gt;% left_join(both_conc %&gt;% select(sampleid, glycoursodeoxycholic_acid, tauroursodeoxycholic_acid, ursodeoxycholic_acid)) %&gt;% ggplot(aes(y=log10(`ursodeoxycholic_acid`+2.5), x=log10(secondary_pool+2.5)))+ geom_point(size=0.8, alpha=0.4)+ geom_smooth(method=&quot;lm&quot;)+ stat_cor(method = &quot;pearson&quot;)+ #ylab(&quot;log10(UDCA)&quot;)+ #xlab(&quot;log10(PS_nonUDCA)&quot;)+ theme_classic() 2.3 Create correlation plots to evaluate association of UDCA with all individual BAs library(corrplot) precor_data&lt;- filtered_combined_table %&gt;% column_to_rownames(&quot;sampleid&quot;) cor_data&lt;-cor(precor_data, use = &quot;complete.obs&quot;) corrplot(cor_data) 2.3.1 Visualization of significant correlations of UDCA with individual BAs (R&gt;0.4) precor_data_selected&lt;- filtered_combined_table %&gt;% column_to_rownames(&quot;sampleid&quot;) %&gt;% select(ursodeoxycholic_acid, ursocholic_acid, beta_muricholic_acid, ursodeoxycholic_acid_3_sulfate, x7_ketodeoxycholic_acid, x7_ketolithocholic_acid, gamma_muricholic_acid, cholic_acid, chenodeoxycholic_acid, x3_oxo_cholic_acid) cor_data_selected&lt;-cor(precor_data_selected, use = &quot;complete.obs&quot;) corrplot(cor_data_selected, method = &quot;number&quot;, type = &quot;upper&quot;) "],["create-the-bile-acid-pools-figure-4-supplementary-figure-68.html", "Chapter 3 Create the bile acid pools (figure 4, supplementary figure 6,8) 3.1 Create BA pools first for peri-GVHD-onset timepoint 3.2 Create BA pools for peri-engraftment timepoint", " Chapter 3 Create the bile acid pools (figure 4, supplementary figure 6,8) 3.1 Create BA pools first for peri-GVHD-onset timepoint later&lt;- cohort_BAS %&gt;%filter(later==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% select(sampleid, GI_GVHD) %&gt;% left_join(conc_all_filtered) #prep dataset prepping each BA depending on its classifications later_pools&lt;-later %&gt;% gather(&quot;bile_acid&quot;, &quot;value&quot;, names(.)[5]:names(.)[ncol(.)]) %&gt;% categorize_bile_acids(ba_families) #replace NAs with 0 to be able to add sums later_pools[is.na(later_pools)]&lt;-0 later_pools_final&lt;-later_pools %&gt;% #gather(&quot;bile_acid&quot;, &quot;value&quot;, names(.)[2]:names(.)[ncol(.)]) %&gt;% #summarise(sum_group=sum(value)) group_by(sampleid) %&gt;% summarise(across(where(is.numeric), sum)) 3.1.1 Plot: TBAs (total_BAs), PBAs (primary_pool), SBAs (secondary_pool), nonUDCA SBAs (secondary_nonUDCA), conjugated (conjugated_pool), unconjugated (unconjugated_pool), sulfated (sulfated_pool) later_pools_final %&gt;% left_join(cohort_BAS) %&gt;% mutate(GI_GVHD=ifelse(GI_GVHD==&quot;Y&quot;, &quot;GVHD&quot;, &quot;CTRL&quot;)) %&gt;% mutate(sp_ratio=secondary_pool/primary_pool) %&gt;% mutate(sp_nonUDCA_ratio=secondary_nonUDCA/primary_pool) %&gt;% mutate(unconj_conj=unconjugated_pool/conjugated_pool) %&gt;% ggplot(aes(x=GI_GVHD, y=log10(unconj_conj), colour=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(unconj_conj)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;CTRL&quot;, &quot;GVHD&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 3.1.2 Create pies dataset_pre&lt;-later_pools_final %&gt;% gather(&quot;BA_pool&quot;, &quot;value&quot;, names(.)[2]:names(.)[ncol(.)]) %&gt;% left_join(cohort_BAS %&gt;% select(sampleid, GI_GVHD, later, ursodiol)) %&gt;% filter(later==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% select(-ursodiol, -later) %&gt;% group_by(GI_GVHD, BA_pool) %&gt;% summarise(ave_pool=ave(value)) %&gt;% slice(1) dataset_pre2&lt;-dataset_pre %&gt;% #filter(BA_pool==&quot;primary_pool&quot;|BA_pool==&quot;secondary_nonUDCA&quot;) %&gt;% #to evaluate nonUDCA secondary and primary polls #filter(BA_pool==&quot;primary_pool&quot;|BA_pool==&quot;secondary_pool&quot;) %&gt;% #to evaluate total secondary filter(BA_pool==&quot;glycine_pool&quot;|BA_pool==&quot;taurine_pool&quot;|BA_pool==&quot;sulfated_pool&quot;|BA_pool==&quot;unconjugated_pool&quot;) %&gt;% rename(group=BA_pool) %&gt;% rename(value=ave_pool) %&gt;% ungroup() %&gt;% group_by(GI_GVHD) %&gt;% mutate(sum_value=sum(value)) %&gt;% mutate(perc=value/sum_value) %&gt;% mutate(labels = scales::percent(perc)) %&gt;% ungroup() #only run below when evaluating glycine/taurine conjugation as wel #define order of piechart for glycine/taurin conjugation dataset_pre2$group &lt;- factor(dataset_pre2$group, levels = c(&quot;glycine_pool&quot;, &quot;taurine_pool&quot;,&quot;unconjugated_pool&quot;,&quot;sulfated_pool&quot;)) cp&lt;-coord_polar(theta=&quot;y&quot;) cp$is_free&lt;-function()TRUE ggplot(dataset_pre2, aes(x=&quot;&quot;, y=perc, fill=group))+ geom_bar(stat=&quot;identity&quot;, width=1)+cp+ facet_wrap(.~GI_GVHD, scales=&quot;free&quot;)+ geom_text(aes(label = labels), position = position_stack(vjust = 0.5)) + theme_void()+ theme(axis.ticks=element_blank(), axis.title=element_blank(), axis.text.y=element_blank())+ scale_fill_manual(values=c(&quot;green4&quot;,&quot;chartreuse3&quot;,&quot;dodgerblue2&quot;,&quot;purple2&quot;)) #to evaluated amidation/sulfation 3.2 Create BA pools for peri-engraftment timepoint periengr_conc&lt;- cohort_BAS %&gt;%filter(periengr==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% select(sampleid, GI_GVHD) %&gt;% left_join(conc_all_filtered) %&gt;% select(-`beta_muricholic_acid`, -`omega_muricholic_acid`) #remove since it is not measured in all samples #prep dataset prepping each BA depending on its classifications periengr_pools&lt;-periengr_conc %&gt;% gather(&quot;bile_acid&quot;, &quot;value&quot;, names(.)[3]:names(.)[ncol(.)]) %&gt;% categorize_bile_acids(ba_families) #replace NAs with 0 to be able to add sums periengr_pools[is.na(periengr_pools)]&lt;-0 #final table with each group sum periengr_pools_final&lt;-periengr_pools %&gt;% group_by(sampleid) %&gt;% summarise(across(where(is.numeric), sum)) 3.2.1 Plot BA pools and GVHD; can plot total BAs (total_BAs), PBAs (primary_pool), SBAs (secondary_pool), nonUDCA SBAs (secondary_nonUDCA), conjugated (conjugated_pool), unconjugated (unconjugated_pool), sulfated_pool, secondary/primary ratio and secondary*/primary ratio periengr_pools_final %&gt;% left_join(cohort_BAS) %&gt;% mutate(GI_GVHD=ifelse(GI_GVHD==&quot;Y&quot;, &quot;GVHD&quot;, &quot;CTRL&quot;)) %&gt;% mutate(sp_ratio=secondary_pool/primary_pool) %&gt;% mutate(sp_nonUDCA_ratio=secondary_nonUDCA/primary_pool) %&gt;% ggplot(aes(x=GI_GVHD, y=log10(sulfated_pool), colour=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ #ylab(&quot;log10(sulfated_pool)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;CTRL&quot;, &quot;GVHD&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 3.2.2 Create pies dataset_pre&lt;-periengr_pools_final %&gt;% gather(&quot;BA_pool&quot;, &quot;value&quot;, names(.)[2]:names(.)[ncol(.)]) %&gt;% left_join(cohort_BAS %&gt;% select(sampleid, GI_GVHD, ursodiol)) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% group_by(GI_GVHD, BA_pool) %&gt;% summarise(ave_pool=ave(value)) %&gt;% slice(1) dataset_pre2&lt;-dataset_pre %&gt;% filter(BA_pool==&quot;primary_pool&quot;|BA_pool==&quot;secondary_nonUDCA&quot;) %&gt;% #to evaluate nonUDCA secondary and primary #filter(BA_pool==&quot;primary_pool&quot;|BA_pool==&quot;secondary_pool&quot;) %&gt;% #to evaluate total secondary #filter(BA_pool==&quot;glycine_pool&quot;|BA_pool==&quot;taurine_pool&quot;|BA_pool==&quot;sulfated_pool&quot;|BA_pool==&quot;unconjugated_pool&quot;) %&gt;% rename(group=BA_pool) %&gt;% rename(value=ave_pool) %&gt;% ungroup() %&gt;% group_by(GI_GVHD) %&gt;% mutate(sum_value=sum(value)) %&gt;% mutate(perc=value/sum_value) %&gt;% mutate(labels = scales::percent(perc)) %&gt;% ungroup() #only run to evaluate glycine/taurine conjugation #define order of piechart for glycine/taurin conjugation #dataset_pre2$group &lt;- factor(dataset_pre2$group, levels = c(&quot;glycine_pool&quot;, &quot;taurine_pool&quot;,&quot;unconjugated_pool&quot;,&quot;sulfated_pool&quot;)) cp&lt;-coord_polar(theta=&quot;y&quot;) cp$is_free&lt;-function()TRUE ggplot(dataset_pre2, aes(x=&quot;&quot;, y=perc, fill=group))+ geom_bar(stat=&quot;identity&quot;, width=1)+cp+ facet_wrap(.~GI_GVHD, scales=&quot;free&quot;)+ geom_text(aes(label = labels), position = position_stack(vjust = 0.5)) + theme_void()+ theme(axis.ticks=element_blank(), axis.title=element_blank(), axis.text.y=element_blank())+ #scale_fill_manual(values=c(&quot;green4&quot;,&quot;chartreuse3&quot;,&quot;dodgerblue2&quot;,&quot;purple2&quot;)) scale_fill_manual(values=c(&quot;#E7861B&quot;,&quot;darkgoldenrod1&quot;)) #for primary/secondary "],["evaluate-t-cell-modulatory-bas-in-patients-with-gvhd-vs-controls-figure-4.html", "Chapter 4 Evaluate T cell modulatory BAs in patients with GVHD vs controls (figure 4) 4.1 3oxoLCA 4.2 isoLCA 4.3 isoDCA 4.4 OMCA", " Chapter 4 Evaluate T cell modulatory BAs in patients with GVHD vs controls (figure 4) 4.1 3oxoLCA filtered_combined_table %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% ggplot(aes(y=log10(dehydrolithocholic_acid+25000), x=GI_GVHD, color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(3oxoLCA)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 4.2 isoLCA filtered_combined_table %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% ggplot(aes(y=log10(isolithocholic_acid+25000), x=GI_GVHD, color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(isoLCA)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 4.3 isoDCA filtered_combined_table %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% ggplot(aes(y=log10(isodeoxycholic_acid+25000), x=GI_GVHD, color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(isoDCA)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 4.4 OMCA conc_all_filtered %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) %&gt;% filter(ursodiol==&quot;Y&quot;) %&gt;% ggplot(aes(y=log10(omega_muricholic_acid+2.5), x=GI_GVHD, color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(OMCA)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) "],["shotgun-metagenomic-sequencing-evaluate-genes-of-interest-figure-5-supplement-figure-10.html", "Chapter 5 Shotgun metagenomic sequencing: Evaluate genes of interest (figure 5, supplement figure 10) 5.1 BSH 5.2 Bai operon gene 5.3 Bile acid related bacteria", " Chapter 5 Shotgun metagenomic sequencing: Evaluate genes of interest (figure 5, supplement figure 10) 5.1 BSH 5.1.1 Evaluate BSH abundance at peri-GVHD onset BSH_metalphlan %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) %&gt;% ggplot(aes(x=GI_GVHD, y=log10(cpm+0.55), color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(BSH)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 5.1.2 Evaluate BSH abundance at peri-engraftment time point BSH_metalphlan %&gt;% left_join(cohort_BAS) %&gt;% filter(periengr==&quot;Y&quot;) %&gt;% ggplot(aes(x=GI_GVHD, y=log10(cpm+0.05), color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(BSH)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 5.2 Bai operon gene 5.2.1 Evaluate correlation of bai operon gene sum and nonUDCA secondary BAs bai_genes_clean %&gt;% distinct(sampleid, bai_operon_sum ) %&gt;% inner_join(both_conc_pools_final) %&gt;% ggplot(aes(x=log(secondary_nonUDCA), y=log(bai_operon_sum+0.05)))+ geom_point(alpha=0.6)+ stat_cor(method=&quot;pearson&quot;)+ geom_smooth(method=&quot;lm&quot;)+ theme_classic()+ ylab(&quot;bai operon log10(cpm)&quot;)+ xlab(&quot;SBAs* log10(pmol/mg)&quot;) 5.2.2 Bai operon gene sum in peri-GVHD onset bai_genes_clean %&gt;% distinct(sampleid, bai_operon_sum ) %&gt;% inner_join(cohort_BAS %&gt;% select(sampleid, GI_GVHD, later) %&gt;% filter(later==&quot;Y&quot;)) %&gt;% ggplot(aes(x=GI_GVHD, y=log(bai_operon_sum+0.01), color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5) + ylab(&quot;log10(bai_operon_sum)&quot;) + xlab(&quot;&quot;) + theme_classic() + stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;)) + theme(legend.position=&quot;none&quot;) 5.2.3 Bai operon individual gene abundance bai_genes_clean %&gt;% inner_join(cohort_BAS %&gt;% select(sampleid, GI_GVHD, later) %&gt;% filter(later==&quot;Y&quot;)) %&gt;% ggplot(aes(x=GI_GVHD, y=log(cpm+0.01), color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(cpm)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;)+ facet_grid(.~gene) 5.3 Bile acid related bacteria 5.3.1 Eggerthella lenta taxa_bas_later %&gt;% ggplot(aes(x=GI_GVHD, y=log10(eggerthella_lenta+ 1.5e-08), color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(Eggerthella lenta)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;N&quot;, &quot;Y&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) 5.3.2 Ruminococcus gnavus taxa_bas_later %&gt;% ggplot(aes(x=GI_GVHD, y=log10(ruminococcus_gnavus+ 1.4e-07), color=GI_GVHD))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(Ruminococcus gnavus)&quot;)+ xlab(&quot;&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;N&quot;, &quot;Y&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;dodgerblue4&quot;, &quot;red3&quot;))+ theme(legend.position=&quot;none&quot;) "],["create-landscape-of-all-peri-gvhd-onset-samples-figure-5.html", "Chapter 6 Create landscape of all peri-GVHD-onset samples (figure 5) 6.1 Define sample order from higher nonUDCA secondary BAs to lower 6.2 GI GVHD plot 6.3 SBA plot 6.4 A-diversity plot 6.5 Bile acid related genes 6.6 Microbiome composition 6.7 Add all plots together", " Chapter 6 Create landscape of all peri-GVHD-onset samples (figure 5) 6.1 Define sample order from higher nonUDCA secondary BAs to lower samples_key&lt;-BSH_metalphlan %&gt;% distinct(sampleid) %&gt;% left_join(later_pools_final %&gt;% select(sampleid, secondary_nonUDCA)) %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) %&gt;% arrange(desc(secondary_nonUDCA)) %&gt;% left_join(ursodiol) %&gt;% filter(ursodiol2==&quot;Y&quot;) level_order &lt;- samples_key$sampleid 6.2 GI GVHD plot gi_gvhd_plot&lt;-cohort_BAS %&gt;% filter(later==&quot;Y&quot;) %&gt;% ggplot((aes(x = factor(sampleid, levels = level_order), y = 1, fill = GI_GVHD))) + geom_raster(color = &quot;black&quot;, size = 0.5) + theme_classic()+ theme(axis.text.x=element_blank())+ xlab(&quot;&quot;)+ ylab(&quot;&quot;)+ scale_fill_manual(values=c(&quot;white&quot;, &quot;dodgerblue4&quot;))+ theme(axis.text.y = element_blank())+ theme(legend.position = &quot;none&quot;) #only for plotting reasons gi_gvhd_plot 6.3 SBA plot sba_plot&lt;-ggplot(samples_key, aes(x=factor(sampleid, level=level_order), y=log10(secondary_nonUDCA)))+ geom_point(size=3)+theme_classic()+ ylab(&quot;log(SBAs*)&quot;)+ theme(axis.text.x=element_blank())+ xlab(&quot;&quot;) sba_plot 6.4 A-diversity plot adiv_pre&lt;-cohort_BAS %&gt;% filter(later==&quot;Y&quot;) %&gt;% left_join(asv_alpha_all) %&gt;% #add a-diversity inner_join(samples_key) %&gt;% arrange(desc(secondary_nonUDCA)) %&gt;% mutate(rank = 1:nrow(.)) adiv_plot&lt;-ggplot(adiv_pre, aes(x = rank, y = simpson_reciprocal)) + geom_point(size=3) + geom_smooth(method = &quot;loess&quot;) + theme_classic() + ylab(&quot;a-diversity&quot;) + #xlab(&quot;sampleid&quot;) + theme(axis.text.x = element_blank()) + xlab(&quot;&quot;) + scale_x_discrete(limits = adiv_pre$rank[order(-adiv_pre$rank)]) adiv_plot 6.5 Bile acid related genes bai_genes_clean$sampleid &lt;-gsub(&quot;FMT_&quot;, &quot;FMT.&quot;, bai_genes_clean$sampleid) ba_genes_pre&lt;-samples_key %&gt;% select(sampleid, GI_GVHD, secondary_nonUDCA) %&gt;% left_join(BSH_metalphlan %&gt;% select(sampleid, cpm, KOID)) %&gt;% rename(gene=KOID) %&gt;% mutate(gene=ifelse(gene==&quot;K01442&quot;, &quot;BSH&quot;, NA)) %&gt;% distinct() %&gt;% spread(key=gene, value=cpm, fill=0) operon_genes_pre&lt;-samples_key %&gt;% left_join(bai_genes_clean) %&gt;% select(sampleid, cpm, gene) %&gt;% distinct() %&gt;% spread(key=gene, value=cpm, fill=0) pre_bai_plot&lt;-ba_genes_pre %&gt;% left_join(operon_genes_pre) %&gt;% select(-GI_GVHD, -secondary_nonUDCA) %&gt;% gather(&quot;gene&quot;, &quot;cpm&quot;, names(.)[2]:names(.)[ncol(.)]) bai_plot&lt;-pre_bai_plot %&gt;% ggplot(aes(x=factor(sampleid, level=level_order), y=gene, fill=log10(cpm+0.05)))+ geom_tile()+ xlab(&quot;&quot;)+ ylab(&quot;bile acid genes&quot;)+ scale_fill_gradient(low=&quot;white&quot;, high=&quot;red&quot;)+ theme(axis.text.x=element_blank())+ theme(legend.position = &quot;none&quot;) #only for plotting reasons bai_plot 6.6 Microbiome composition setDT(asv_annotation_blast_color_ag) asv_color_base_set = unique(asv_annotation_blast_color_ag[,.(color_label_group,color_base)]) color_base_set_asv_carT = asv_color_base_set$color_base names(color_base_set_asv_carT) =asv_color_base_set$color_label_group; gg = ggplot(asv_color_base_set, aes(color_label_group,y=1,fill=color_label_group)) + geom_tile() + scale_fill_manual(values = color_base_set_asv_carT) + theme_classic() + theme(axis.text.x = element_text(angle=60,hjust = 1)) + theme(legend.position = &quot;none&quot;) #color_set_asv_carT maps each distinct taxonomic group to its corresponding color. asv_color_set = unique(asv_annotation_blast_color_ag[,.(color,color_label_group_distinct,color_label_group,color_base)]) color_set_asv_carT = asv_color_set$color names(color_set_asv_carT) =asv_color_set$color_label_group_distinct; setDT(counts_samples) setDT(asv_annotation_blast_color_ag) m = merge(counts_samples[,.(asv_key,sampleid, count,count_relative,count_total)], asv_annotation_blast_color_ag[,.(asv_key,color_label_group_distinct)]); sample_composition &lt;- m %&gt;% left_join(cohort_BAS %&gt;% select(PID, sampleid)) %&gt;% left_join(cohort_BAS) %&gt;% filter(later==&quot;Y&quot;) m1&lt;-sample_composition %&gt;% group_by(sampleid, color_label_group_distinct) %&gt;% inner_join(samples_key) %&gt;% mutate(sampleid = fct_reorder(sampleid, desc(secondary_nonUDCA))) m1$color_label_group_distinct = factor(m1$color_label_group_distinct,levels = sort(unique(m1$color_label_group_distinct),decreasing = T)); gg_composition = ggplot(m1, aes(x=factor(sampleid, levels=level_order), y=count_relative, fill=color_label_group_distinct) ) + geom_bar(stat = &quot;identity&quot;,position=&quot;fill&quot;,width = 1) + theme_classic() + theme(axis.text.x = element_blank(), axis.text.y = element_blank(), legend.position = &quot;none&quot;) + xlab(&quot;&quot;)+ scale_fill_manual(values = color_set_asv_carT); print(gg_composition) 6.7 Add all plots together library(cowplot) last&lt;-plot_grid(gi_gvhd_plot, sba_plot, bai_plot, adiv_plot, gg_composition, #labels = c(&quot;A&quot;, &quot;B&quot;, &quot;C&quot;, &quot;D&quot;, &quot;E&quot;), ncol = 1, nrow = 5, align = &quot;v&quot;,axis = &#39;l&#39;, width = 40, height = 20, rel_heights = c(1.8, 4 ,6, 6, 10)) last "],["diversity-bai-operon-and-domination.html", "Chapter 7 Diversity, bai operon and domination 7.1 Evaluate correlation of a-diversity and bai operon sum 7.2 Identify patients with monodomination by 16S 7.3 Domination and a-diversity 7.4 Domination and bai operon 7.5 SBAs and domination", " Chapter 7 Diversity, bai operon and domination 7.1 Evaluate correlation of a-diversity and bai operon sum data_ba&lt;- asv_alpha_all %&gt;% inner_join(bai_genes_clean %&gt;% distinct(sampleid, bai_operon_sum)) %&gt;% left_join(cohort_BAS) %&gt;% filter(ursodiol==&quot;Y&quot;) data_ba %&gt;% ggplot(aes(x=log10(simpson_reciprocal), y=log10(bai_operon_sum+0.01)))+ geom_point(alpha=0.6)+ stat_cor(method=&quot;pearson&quot;)+ geom_smooth(method=&quot;lm&quot;)+ theme_classic()+ ylab(&quot;bai operon log10(cpm)&quot;)+ xlab(&quot;a-diversity&quot;) 7.2 Identify patients with monodomination by 16S #create dataset with asv samples_asv&lt;-cohort_BAS %&gt;% filter(later==&quot;Y&quot;) %&gt;% select(sampleid) %&gt;% inner_join(counts_samples %&gt;% select(sampleid, asv_key, count, count_total)) %&gt;% inner_join(asv_annotation_blast_ag %&gt;% select(asv_key, kingdom, phylum, class, ordr, family, genus)) %&gt;% mutate(relab=count/count_total) %&gt;% group_by(sampleid, genus) pathogens_pre&lt;- samples_asv %&gt;% filter(genus==&quot;Enterococcus&quot;|genus==&quot;Streptococcus&quot;|phylum==&quot;Proteobacteria&quot;) %&gt;% mutate(enterococcus=ifelse(genus==&quot;Enterococcus&quot;, relab, 0)) %&gt;% mutate(streptococcus=ifelse(genus==&quot;Streptococcus&quot;, relab, 0)) %&gt;% mutate(proteobacteria=ifelse(phylum==&quot;Proteobacteria&quot;, relab, 0)) %&gt;% mutate(enterococcus_dom=ifelse(enterococcus&gt;=0.3, &quot;Y&quot;, &quot;N&quot;)) %&gt;% mutate(streptococcus_dom=ifelse(streptococcus&gt;=0.3, &quot;Y&quot;, &quot;N&quot;)) %&gt;% mutate(proteobacteria_dom=ifelse(proteobacteria&gt;=0.3, &quot;Y&quot;, &quot;N&quot;)) %&gt;% mutate(any_dom=ifelse(enterococcus_dom==&quot;Y&quot;|streptococcus_dom==&quot;Y&quot;|proteobacteria_dom==&quot;Y&quot;, &quot;Y&quot;, &quot;N&quot;)) %&gt;% group_by(sampleid) %&gt;% arrange(desc(any_dom)) %&gt;% slice(1) 7.3 Domination and a-diversity pathogens_pre %&gt;% inner_join(asv_alpha_all) %&gt;% ggplot(aes(x=any_dom, y=simpson_reciprocal, color=any_dom))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(a-div)&quot;)+ xlab(&quot;domination&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;turquoise4&quot;,&quot;darkviolet&quot;))+ theme(legend.position=&quot;none&quot;) 7.4 Domination and bai operon pathogens_pre %&gt;% inner_join(bai_genes_clean %&gt;% distinct(sampleid, bai_operon_sum)) %&gt;% ggplot(aes(x=any_dom, y=log10(bai_operon_sum+0.01), color=any_dom))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(bai sum)&quot;)+ xlab(&quot;domination&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;turquoise4&quot;,&quot;darkviolet&quot;))+ theme(legend.position=&quot;none&quot;) 7.5 SBAs and domination pathogens_pre %&gt;% inner_join(later_pools_final) %&gt;% ggplot(aes(x=any_dom, y=log10(secondary_nonUDCA), color=any_dom))+ geom_boxplot(width=0.2, lwd=0.8, outlier.shape = NA) + geom_jitter(width=0.3, alpha=0.3, size=2.5)+ ylab(&quot;log10(SBAs*)&quot;)+ xlab(&quot;domination&quot;)+ theme_classic()+ stat_compare_means(comparisons=list(c(&quot;Y&quot;, &quot;N&quot;)), method=&quot;wilcox.test&quot;, correct=FALSE)+ scale_color_manual(values=c(&quot;turquoise4&quot;,&quot;darkviolet&quot;))+ theme(legend.position=&quot;none&quot;) "],["evaluation-of-udca-exposure-and-clinical-outcomes.html", "Chapter 8 Evaluation of UDCA exposure and clinical outcomes 8.1 Prepare the patient outcome table 8.2 Evaluate ursodiol exposure and overall survival 8.3 Evaluation of cumulative incidences", " Chapter 8 Evaluation of UDCA exposure and clinical outcomes 8.1 Prepare the patient outcome table library(tidycmprsk) library(ggsurvfit) library(tidycmprsk) library(gtsummary) patients_urso_CIF2&lt;-patients_urso_CIF %&gt;% mutate(GRM_mortality=ifelse(death==F &amp; relapse==F &amp; pod==&quot;N&quot;, 0, ifelse(relapse==T | pod ==&quot;Y&quot; | (cod==&quot;Disease Progression&quot;|cod==&quot;Recurrence of primary disease&quot;|cod==&quot;Malignant disease&quot;|cod==&quot;Relapse&quot;),2, ifelse(cod==&quot;GvHD&quot;|cod==&quot;GvHD/Infection&quot;|(gvhd==T &amp; death==T),1,3)))) %&gt;% mutate(GRM_mortality = ifelse(is.na(GRM_mortality),3,GRM_mortality)) %&gt;% mutate(GRM_mortality = factor(GRM_mortality,levels=c(0,1,2,3),labels=c(&quot;Censored&quot;, &quot;GRM&quot;, &quot;Relapse/PoD&quot;,&quot;Other&quot;))) %&gt;% mutate(TRM_mortality=ifelse(death==F &amp; relapse==F &amp; pod==&quot;N&quot;, 0, ifelse(relapse==T | pod ==&quot;Y&quot; | (cod==&quot;Disease Progression&quot;|cod==&quot;Recurrence of primary disease&quot;|cod==&quot;Malignant disease&quot;|cod==&quot;Relapse&quot;),2, 1))) %&gt;% mutate(TRM_mortality = ifelse(is.na(TRM_mortality),1,TRM_mortality)) %&gt;% mutate(TRM_mortality = factor(TRM_mortality,levels=c(0,1,2),labels=c(&quot;Censored&quot;,&quot;TRM&quot;,&quot;Relapse/PoD&quot;))) table(patients_urso_CIF2$GRM_mortality) ## ## Censored GRM Relapse/PoD Other ## 624 191 386 100 patients_urso_CIF2$GRM_time &lt;- patients_urso_CIF2$OS patients_urso_CIF2$GRM_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;N&quot;] = patients_urso_CIF2$relapse_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;N&quot;] patients_urso_CIF2$GRM_time[patients_urso_CIF2$relapse==F &amp; patients_urso_CIF2$pod==&quot;Y&quot;] = patients_urso_CIF2$pod_time[patients_urso_CIF2$relapse==F &amp; patients_urso_CIF2$pod==&quot;Y&quot;] patients_urso_CIF2$GRM_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;Y&quot;] = min(patients_urso_CIF2$pod_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;Y&quot;], patients_urso_CIF2$relapse_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;Y&quot;]) patients_urso_CIF2$TRM_time &lt;- patients_urso_CIF2$OS patients_urso_CIF2$TRM_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;N&quot;] = patients_urso_CIF2$relapse_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;N&quot;] patients_urso_CIF2$TRM_time[patients_urso_CIF2$relapse==F &amp; patients_urso_CIF2$pod==&quot;Y&quot;] = patients_urso_CIF2$pod_time[patients_urso_CIF2$relapse==F &amp; patients_urso_CIF2$pod==&quot;Y&quot;] patients_urso_CIF2$TRM_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;Y&quot;] = min(patients_urso_CIF2$pod_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;Y&quot;], patients_urso_CIF2$relapse_time[patients_urso_CIF2$relapse==T &amp; patients_urso_CIF2$pod==&quot;Y&quot;]) patients_urso_CIF2 &lt;- patients_urso_CIF2 %&gt;% mutate(GRM_mortality_2yr = ifelse(GRM_time &gt; 24,1,GRM_mortality), GRM_time_2yr = ifelse(GRM_time &gt; 24,24,GRM_time), TRM_mortality_2yr = ifelse(TRM_time &gt; 24,1,TRM_mortality), TRM_time_2yr = ifelse(TRM_time &gt; 24,24,TRM_time), death_2yr = ifelse(OS &gt; 24,FALSE,death), OS_2yr = ifelse(OS &gt; 24,24,OS), GRM_mortality_2yr = factor(GRM_mortality_2yr,levels=1:4,labels=c(&quot;Censored&quot;,&quot;GRM&quot;,&quot;Relapse/PoD&quot;, &quot;Other&quot;)), TRM_mortality_2yr = factor(TRM_mortality_2yr,levels=1:3,labels=c(&quot;Censored&quot;, &quot;TRM&quot;, &quot;Relapse/PoD&quot;))) patients_urso_CIF2 &lt;- patients_urso_CIF2 %&gt;% mutate(donor_new=ifelse(donor_match==&quot;MMRD&quot;, &quot;haplo&quot;, donor_match)) 8.2 Evaluate ursodiol exposure and overall survival 8.2.1 Univariable analysis KM.OS &lt;- survfit2(Surv(OS_2yr,as.numeric(death_2yr))~ursodiol2,data=patients_urso_CIF2) KM.OS %&gt;% ggsurvfit() + add_censor_mark() + add_confidence_interval() + add_risktable(times=c(0,6, 12, 18, 24)) 8.2.2 Multivariable analysis coxfit &lt;- survival::coxph(Surv(OS_2yr,as.numeric(death_2yr))~age+sex+donor_match+graft+intensity+ursodiol2,data=patients_urso_CIF2) coxfit %&gt;% tbl_regression(exponentiate=TRUE) %&gt;% bold_p() #vjaifwyavj table { font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji'; -webkit-font-smoothing: antialiased; -moz-osx-font-smoothing: grayscale; } #vjaifwyavj thead, #vjaifwyavj tbody, #vjaifwyavj tfoot, #vjaifwyavj tr, #vjaifwyavj td, #vjaifwyavj th { border-style: none; } #vjaifwyavj p { margin: 0; padding: 0; } #vjaifwyavj .gt_table { display: table; border-collapse: collapse; line-height: normal; margin-left: auto; margin-right: auto; color: #333333; font-size: 16px; font-weight: normal; font-style: normal; background-color: #FFFFFF; width: auto; border-top-style: solid; border-top-width: 2px; border-top-color: #A8A8A8; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #A8A8A8; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; } #vjaifwyavj .gt_caption { padding-top: 4px; padding-bottom: 4px; } #vjaifwyavj .gt_title { color: #333333; font-size: 125%; font-weight: initial; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; border-bottom-color: #FFFFFF; border-bottom-width: 0; } #vjaifwyavj .gt_subtitle { color: #333333; font-size: 85%; font-weight: initial; padding-top: 3px; padding-bottom: 5px; padding-left: 5px; padding-right: 5px; border-top-color: #FFFFFF; border-top-width: 0; } #vjaifwyavj .gt_heading { background-color: #FFFFFF; text-align: center; border-bottom-color: #FFFFFF; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #vjaifwyavj .gt_bottom_border { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #vjaifwyavj .gt_col_headings { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #vjaifwyavj .gt_col_heading { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 6px; padding-left: 5px; padding-right: 5px; overflow-x: hidden; } #vjaifwyavj .gt_column_spanner_outer { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; padding-top: 0; padding-bottom: 0; padding-left: 4px; padding-right: 4px; } #vjaifwyavj .gt_column_spanner_outer:first-child { padding-left: 0; } #vjaifwyavj .gt_column_spanner_outer:last-child { padding-right: 0; } #vjaifwyavj .gt_column_spanner { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 5px; overflow-x: hidden; display: inline-block; width: 100%; } #vjaifwyavj .gt_spanner_row { border-bottom-style: hidden; } #vjaifwyavj .gt_group_heading { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; text-align: left; } #vjaifwyavj .gt_empty_group_heading { padding: 0.5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: middle; } #vjaifwyavj .gt_from_md > :first-child { margin-top: 0; } #vjaifwyavj .gt_from_md > :last-child { margin-bottom: 0; } #vjaifwyavj .gt_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; margin: 10px; border-top-style: solid; border-top-width: 1px; border-top-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; overflow-x: hidden; } #vjaifwyavj .gt_stub { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; } #vjaifwyavj .gt_stub_row_group { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; vertical-align: top; } #vjaifwyavj .gt_row_group_first td { border-top-width: 2px; } #vjaifwyavj .gt_row_group_first th { border-top-width: 2px; } #vjaifwyavj .gt_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #vjaifwyavj .gt_first_summary_row { border-top-style: solid; border-top-color: #D3D3D3; } #vjaifwyavj .gt_first_summary_row.thick { border-top-width: 2px; } #vjaifwyavj .gt_last_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #vjaifwyavj .gt_grand_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #vjaifwyavj .gt_first_grand_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-top-style: double; border-top-width: 6px; border-top-color: #D3D3D3; } #vjaifwyavj .gt_last_grand_summary_row_top { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: double; border-bottom-width: 6px; border-bottom-color: #D3D3D3; } #vjaifwyavj .gt_striped { background-color: rgba(128, 128, 128, 0.05); } #vjaifwyavj .gt_table_body { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #vjaifwyavj .gt_footnotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #vjaifwyavj .gt_footnote { margin: 0px; font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #vjaifwyavj .gt_sourcenotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #vjaifwyavj .gt_sourcenote { font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #vjaifwyavj .gt_left { text-align: left; } #vjaifwyavj .gt_center { text-align: center; } #vjaifwyavj .gt_right { text-align: right; font-variant-numeric: tabular-nums; } #vjaifwyavj .gt_font_normal { font-weight: normal; } #vjaifwyavj .gt_font_bold { font-weight: bold; } #vjaifwyavj .gt_font_italic { font-style: italic; } #vjaifwyavj .gt_super { font-size: 65%; } #vjaifwyavj .gt_footnote_marks { font-size: 75%; vertical-align: 0.4em; position: initial; } #vjaifwyavj .gt_asterisk { font-size: 100%; vertical-align: 0; } #vjaifwyavj .gt_indent_1 { text-indent: 5px; } #vjaifwyavj .gt_indent_2 { text-indent: 10px; } #vjaifwyavj .gt_indent_3 { text-indent: 15px; } #vjaifwyavj .gt_indent_4 { text-indent: 20px; } #vjaifwyavj .gt_indent_5 { text-indent: 25px; } Characteristic HR1 95% CI1 p-value age 1.03 1.02, 1.04 sex     F — —     M 0.95 0.79, 1.15 0.6 donor_match     haplo — —     haplo/MMUD 1.20 0.57, 2.51 0.6     MMRD 1.23 0.16, 9.28 0.8     MMUD 1.23 0.73, 2.07 0.4     MRD 0.74 0.45, 1.21 0.2     MUD 0.82 0.51, 1.32 0.4 graft     BM — —     CD34 0.89 0.60, 1.33 0.6     PBSC 1.15 0.80, 1.67 0.5     UCB 0.75 0.44, 1.28 0.3 intensity     Ablative — —     Nonablative 0.49 0.33, 0.73     Reduced Intensity 1.00 0.74, 1.35 >0.9 ursodiol2     N — —     Y 0.69 0.55, 0.85 1 HR = Hazard Ratio, CI = Confidence Interval 8.3 Evaluation of cumulative incidences 8.3.1 Cumulative incidence of GVHD-related mortality gray.test.GRM &lt;- cuminc(Surv(GRM_time_2yr, GRM_mortality_2yr)~ursodiol2, data=patients_urso_CIF2) gray.test.GRM %&gt;% tbl_cuminc(times= c(6,12,18,24),outcome=&quot;GRM&quot;) %&gt;% add_p() %&gt;% add_n() %&gt;% modify_caption(&quot;Outcome: GRM&quot;) #llsgqrxzpb table { font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji'; -webkit-font-smoothing: antialiased; -moz-osx-font-smoothing: grayscale; } #llsgqrxzpb thead, #llsgqrxzpb tbody, #llsgqrxzpb tfoot, #llsgqrxzpb tr, #llsgqrxzpb td, #llsgqrxzpb th { border-style: none; } #llsgqrxzpb p { margin: 0; padding: 0; } #llsgqrxzpb .gt_table { display: table; border-collapse: collapse; line-height: normal; margin-left: auto; margin-right: auto; color: #333333; font-size: 16px; font-weight: normal; font-style: normal; background-color: #FFFFFF; width: auto; border-top-style: solid; border-top-width: 2px; border-top-color: #A8A8A8; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #A8A8A8; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; } #llsgqrxzpb .gt_caption { padding-top: 4px; padding-bottom: 4px; } #llsgqrxzpb .gt_title { color: #333333; font-size: 125%; font-weight: initial; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; border-bottom-color: #FFFFFF; border-bottom-width: 0; } #llsgqrxzpb .gt_subtitle { color: #333333; font-size: 85%; font-weight: initial; padding-top: 3px; padding-bottom: 5px; padding-left: 5px; padding-right: 5px; border-top-color: #FFFFFF; border-top-width: 0; } #llsgqrxzpb .gt_heading { background-color: #FFFFFF; text-align: center; border-bottom-color: #FFFFFF; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #llsgqrxzpb .gt_bottom_border { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #llsgqrxzpb .gt_col_headings { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #llsgqrxzpb .gt_col_heading { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 6px; padding-left: 5px; padding-right: 5px; overflow-x: hidden; } #llsgqrxzpb .gt_column_spanner_outer { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; padding-top: 0; padding-bottom: 0; padding-left: 4px; padding-right: 4px; } #llsgqrxzpb .gt_column_spanner_outer:first-child { padding-left: 0; } #llsgqrxzpb .gt_column_spanner_outer:last-child { padding-right: 0; } #llsgqrxzpb .gt_column_spanner { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 5px; overflow-x: hidden; display: inline-block; width: 100%; } #llsgqrxzpb .gt_spanner_row { border-bottom-style: hidden; } #llsgqrxzpb .gt_group_heading { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; text-align: left; } #llsgqrxzpb .gt_empty_group_heading { padding: 0.5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: middle; } #llsgqrxzpb .gt_from_md > :first-child { margin-top: 0; } #llsgqrxzpb .gt_from_md > :last-child { margin-bottom: 0; } #llsgqrxzpb .gt_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; margin: 10px; border-top-style: solid; border-top-width: 1px; border-top-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; overflow-x: hidden; } #llsgqrxzpb .gt_stub { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; } #llsgqrxzpb .gt_stub_row_group { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; vertical-align: top; } #llsgqrxzpb .gt_row_group_first td { border-top-width: 2px; } #llsgqrxzpb .gt_row_group_first th { border-top-width: 2px; } #llsgqrxzpb .gt_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #llsgqrxzpb .gt_first_summary_row { border-top-style: solid; border-top-color: #D3D3D3; } #llsgqrxzpb .gt_first_summary_row.thick { border-top-width: 2px; } #llsgqrxzpb .gt_last_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #llsgqrxzpb .gt_grand_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #llsgqrxzpb .gt_first_grand_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-top-style: double; border-top-width: 6px; border-top-color: #D3D3D3; } #llsgqrxzpb .gt_last_grand_summary_row_top { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: double; border-bottom-width: 6px; border-bottom-color: #D3D3D3; } #llsgqrxzpb .gt_striped { background-color: rgba(128, 128, 128, 0.05); } #llsgqrxzpb .gt_table_body { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #llsgqrxzpb .gt_footnotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #llsgqrxzpb .gt_footnote { margin: 0px; font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #llsgqrxzpb .gt_sourcenotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #llsgqrxzpb .gt_sourcenote { font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #llsgqrxzpb .gt_left { text-align: left; } #llsgqrxzpb .gt_center { text-align: center; } #llsgqrxzpb .gt_right { text-align: right; font-variant-numeric: tabular-nums; } #llsgqrxzpb .gt_font_normal { font-weight: normal; } #llsgqrxzpb .gt_font_bold { font-weight: bold; } #llsgqrxzpb .gt_font_italic { font-style: italic; } #llsgqrxzpb .gt_super { font-size: 65%; } #llsgqrxzpb .gt_footnote_marks { font-size: 75%; vertical-align: 0.4em; position: initial; } #llsgqrxzpb .gt_asterisk { font-size: 100%; vertical-align: 0; } #llsgqrxzpb .gt_indent_1 { text-indent: 5px; } #llsgqrxzpb .gt_indent_2 { text-indent: 10px; } #llsgqrxzpb .gt_indent_3 { text-indent: 15px; } #llsgqrxzpb .gt_indent_4 { text-indent: 20px; } #llsgqrxzpb .gt_indent_5 { text-indent: 25px; } Table 8.1: Outcome: GRM Characteristic N Time 6 Time 12 Time 18 Time 24 p-value1 ursodiol2 1,301 0.044     N 7.2% (4.7%, 10%) 11% (7.8%, 15%) 14% (10%, 18%) 16% (12%, 20%)     Y 3.8% (2.7%, 5.1%) 8.1% (6.5%, 9.9%) 10% (8.2%, 12%) 12% (9.8%, 14%) 1 Gray’s Test gray.test.GRM %&gt;% ggcuminc(outcome=&quot;GRM&quot;) + labs( x = &quot;Months after HCT&quot;, y = &quot;Cumulative Incidence (GRM)&quot; ) + add_confidence_interval() + add_risktable(times=c(0,6,12,18,24)) 8.3.2 Cumulative incidence of Relapse/progression of disease gray.test.GRM %&gt;% tbl_cuminc(times= c(6,12,18,24),outcome=&quot;Relapse/PoD&quot;) %&gt;% add_p() %&gt;% add_n() %&gt;% modify_caption(&quot;Outcome: Relapse/PoD&quot;) #dwftapswbc table { font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji'; -webkit-font-smoothing: antialiased; -moz-osx-font-smoothing: grayscale; } #dwftapswbc thead, #dwftapswbc tbody, #dwftapswbc tfoot, #dwftapswbc tr, #dwftapswbc td, #dwftapswbc th { border-style: none; } #dwftapswbc p { margin: 0; padding: 0; } #dwftapswbc .gt_table { display: table; border-collapse: collapse; line-height: normal; margin-left: auto; margin-right: auto; color: #333333; font-size: 16px; font-weight: normal; font-style: normal; background-color: #FFFFFF; width: auto; border-top-style: solid; border-top-width: 2px; border-top-color: #A8A8A8; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #A8A8A8; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; } #dwftapswbc .gt_caption { padding-top: 4px; padding-bottom: 4px; } #dwftapswbc .gt_title { color: #333333; font-size: 125%; font-weight: initial; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; border-bottom-color: #FFFFFF; border-bottom-width: 0; } #dwftapswbc .gt_subtitle { color: #333333; font-size: 85%; font-weight: initial; padding-top: 3px; padding-bottom: 5px; padding-left: 5px; padding-right: 5px; border-top-color: #FFFFFF; border-top-width: 0; } #dwftapswbc .gt_heading { background-color: #FFFFFF; text-align: center; border-bottom-color: #FFFFFF; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #dwftapswbc .gt_bottom_border { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #dwftapswbc .gt_col_headings { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #dwftapswbc .gt_col_heading { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 6px; padding-left: 5px; padding-right: 5px; overflow-x: hidden; } #dwftapswbc .gt_column_spanner_outer { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; padding-top: 0; padding-bottom: 0; padding-left: 4px; padding-right: 4px; } #dwftapswbc .gt_column_spanner_outer:first-child { padding-left: 0; } #dwftapswbc .gt_column_spanner_outer:last-child { padding-right: 0; } #dwftapswbc .gt_column_spanner { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 5px; overflow-x: hidden; display: inline-block; width: 100%; } #dwftapswbc .gt_spanner_row { border-bottom-style: hidden; } #dwftapswbc .gt_group_heading { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; text-align: left; } #dwftapswbc .gt_empty_group_heading { padding: 0.5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: middle; } #dwftapswbc .gt_from_md > :first-child { margin-top: 0; } #dwftapswbc .gt_from_md > :last-child { margin-bottom: 0; } #dwftapswbc .gt_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; margin: 10px; border-top-style: solid; border-top-width: 1px; border-top-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; overflow-x: hidden; } #dwftapswbc .gt_stub { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; } #dwftapswbc .gt_stub_row_group { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; vertical-align: top; } #dwftapswbc .gt_row_group_first td { border-top-width: 2px; } #dwftapswbc .gt_row_group_first th { border-top-width: 2px; } #dwftapswbc .gt_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #dwftapswbc .gt_first_summary_row { border-top-style: solid; border-top-color: #D3D3D3; } #dwftapswbc .gt_first_summary_row.thick { border-top-width: 2px; } #dwftapswbc .gt_last_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #dwftapswbc .gt_grand_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #dwftapswbc .gt_first_grand_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-top-style: double; border-top-width: 6px; border-top-color: #D3D3D3; } #dwftapswbc .gt_last_grand_summary_row_top { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: double; border-bottom-width: 6px; border-bottom-color: #D3D3D3; } #dwftapswbc .gt_striped { background-color: rgba(128, 128, 128, 0.05); } #dwftapswbc .gt_table_body { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #dwftapswbc .gt_footnotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #dwftapswbc .gt_footnote { margin: 0px; font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #dwftapswbc .gt_sourcenotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #dwftapswbc .gt_sourcenote { font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #dwftapswbc .gt_left { text-align: left; } #dwftapswbc .gt_center { text-align: center; } #dwftapswbc .gt_right { text-align: right; font-variant-numeric: tabular-nums; } #dwftapswbc .gt_font_normal { font-weight: normal; } #dwftapswbc .gt_font_bold { font-weight: bold; } #dwftapswbc .gt_font_italic { font-style: italic; } #dwftapswbc .gt_super { font-size: 65%; } #dwftapswbc .gt_footnote_marks { font-size: 75%; vertical-align: 0.4em; position: initial; } #dwftapswbc .gt_asterisk { font-size: 100%; vertical-align: 0; } #dwftapswbc .gt_indent_1 { text-indent: 5px; } #dwftapswbc .gt_indent_2 { text-indent: 10px; } #dwftapswbc .gt_indent_3 { text-indent: 15px; } #dwftapswbc .gt_indent_4 { text-indent: 20px; } #dwftapswbc .gt_indent_5 { text-indent: 25px; } Table 8.2: Outcome: Relapse/PoD Characteristic N Time 6 Time 12 Time 18 Time 24 p-value1 ursodiol2 1,301 0.088     N 12% (8.9%, 16%) 18% (14%, 23%) 22% (17%, 26%) 23% (18%, 28%)     Y 15% (13%, 17%) 24% (21%, 26%) 26% (24%, 29%) 28% (25%, 31%) 1 Gray’s Test 8.3.3 Cumulative incidence of mortality non-related to GVHD or relapse/progression of disease gray.test.GRM %&gt;% tbl_cuminc(times= c(6,12,18,24),outcome=&quot;Other&quot;) %&gt;% add_p() %&gt;% add_n() %&gt;% modify_caption(&quot;Outcome: Other&quot;) #tvckjfguqz table { font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji'; -webkit-font-smoothing: antialiased; -moz-osx-font-smoothing: grayscale; } #tvckjfguqz thead, #tvckjfguqz tbody, #tvckjfguqz tfoot, #tvckjfguqz tr, #tvckjfguqz td, #tvckjfguqz th { border-style: none; } #tvckjfguqz p { margin: 0; padding: 0; } #tvckjfguqz .gt_table { display: table; border-collapse: collapse; line-height: normal; margin-left: auto; margin-right: auto; color: #333333; font-size: 16px; font-weight: normal; font-style: normal; background-color: #FFFFFF; width: auto; border-top-style: solid; border-top-width: 2px; border-top-color: #A8A8A8; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #A8A8A8; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; } #tvckjfguqz .gt_caption { padding-top: 4px; padding-bottom: 4px; } #tvckjfguqz .gt_title { color: #333333; font-size: 125%; font-weight: initial; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; border-bottom-color: #FFFFFF; border-bottom-width: 0; } #tvckjfguqz .gt_subtitle { color: #333333; font-size: 85%; font-weight: initial; padding-top: 3px; padding-bottom: 5px; padding-left: 5px; padding-right: 5px; border-top-color: #FFFFFF; border-top-width: 0; } #tvckjfguqz .gt_heading { background-color: #FFFFFF; text-align: center; border-bottom-color: #FFFFFF; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #tvckjfguqz .gt_bottom_border { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #tvckjfguqz .gt_col_headings { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #tvckjfguqz .gt_col_heading { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 6px; padding-left: 5px; padding-right: 5px; overflow-x: hidden; } #tvckjfguqz .gt_column_spanner_outer { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; padding-top: 0; padding-bottom: 0; padding-left: 4px; padding-right: 4px; } #tvckjfguqz .gt_column_spanner_outer:first-child { padding-left: 0; } #tvckjfguqz .gt_column_spanner_outer:last-child { padding-right: 0; } #tvckjfguqz .gt_column_spanner { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 5px; overflow-x: hidden; display: inline-block; width: 100%; } #tvckjfguqz .gt_spanner_row { border-bottom-style: hidden; } #tvckjfguqz .gt_group_heading { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; text-align: left; } #tvckjfguqz .gt_empty_group_heading { padding: 0.5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: middle; } #tvckjfguqz .gt_from_md > :first-child { margin-top: 0; } #tvckjfguqz .gt_from_md > :last-child { margin-bottom: 0; } #tvckjfguqz .gt_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; margin: 10px; border-top-style: solid; border-top-width: 1px; border-top-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; overflow-x: hidden; } #tvckjfguqz .gt_stub { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; } #tvckjfguqz .gt_stub_row_group { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; vertical-align: top; } #tvckjfguqz .gt_row_group_first td { border-top-width: 2px; } #tvckjfguqz .gt_row_group_first th { border-top-width: 2px; } #tvckjfguqz .gt_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #tvckjfguqz .gt_first_summary_row { border-top-style: solid; border-top-color: #D3D3D3; } #tvckjfguqz .gt_first_summary_row.thick { border-top-width: 2px; } #tvckjfguqz .gt_last_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #tvckjfguqz .gt_grand_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #tvckjfguqz .gt_first_grand_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-top-style: double; border-top-width: 6px; border-top-color: #D3D3D3; } #tvckjfguqz .gt_last_grand_summary_row_top { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: double; border-bottom-width: 6px; border-bottom-color: #D3D3D3; } #tvckjfguqz .gt_striped { background-color: rgba(128, 128, 128, 0.05); } #tvckjfguqz .gt_table_body { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #tvckjfguqz .gt_footnotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #tvckjfguqz .gt_footnote { margin: 0px; font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #tvckjfguqz .gt_sourcenotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #tvckjfguqz .gt_sourcenote { font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #tvckjfguqz .gt_left { text-align: left; } #tvckjfguqz .gt_center { text-align: center; } #tvckjfguqz .gt_right { text-align: right; font-variant-numeric: tabular-nums; } #tvckjfguqz .gt_font_normal { font-weight: normal; } #tvckjfguqz .gt_font_bold { font-weight: bold; } #tvckjfguqz .gt_font_italic { font-style: italic; } #tvckjfguqz .gt_super { font-size: 65%; } #tvckjfguqz .gt_footnote_marks { font-size: 75%; vertical-align: 0.4em; position: initial; } #tvckjfguqz .gt_asterisk { font-size: 100%; vertical-align: 0; } #tvckjfguqz .gt_indent_1 { text-indent: 5px; } #tvckjfguqz .gt_indent_2 { text-indent: 10px; } #tvckjfguqz .gt_indent_3 { text-indent: 15px; } #tvckjfguqz .gt_indent_4 { text-indent: 20px; } #tvckjfguqz .gt_indent_5 { text-indent: 25px; } Table 8.3: Outcome: Other Characteristic N Time 6 Time 12 Time 18 Time 24 p-value1 ursodiol2 1,301 0.003     N 4.7% (2.7%, 7.4%) 7.2% (4.7%, 10%) 8.8% (6.0%, 12%) 11% (7.6%, 14%)     Y 4.1% (3.0%, 5.4%) 5.0% (3.8%, 6.5%) 5.4% (4.1%, 7.0%) 5.6% (4.3%, 7.2%) 1 Gray’s Test 8.3.4 Multivariable analysis of GVHD-related mortality fgmodel.GRM &lt;- crr(Surv(GRM_time_2yr,GRM_mortality_2yr)~age+sex+donor_match+graft+intensity+ursodiol2,data=patients_urso_CIF2) fgmodel.GRM %&gt;% tbl_regression(exponentiate=TRUE) %&gt;% bold_p() #fwuqzqmroe table { font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji'; -webkit-font-smoothing: antialiased; -moz-osx-font-smoothing: grayscale; } #fwuqzqmroe thead, #fwuqzqmroe tbody, #fwuqzqmroe tfoot, #fwuqzqmroe tr, #fwuqzqmroe td, #fwuqzqmroe th { border-style: none; } #fwuqzqmroe p { margin: 0; padding: 0; } #fwuqzqmroe .gt_table { display: table; border-collapse: collapse; line-height: normal; margin-left: auto; margin-right: auto; color: #333333; font-size: 16px; font-weight: normal; font-style: normal; background-color: #FFFFFF; width: auto; border-top-style: solid; border-top-width: 2px; border-top-color: #A8A8A8; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #A8A8A8; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; } #fwuqzqmroe .gt_caption { padding-top: 4px; padding-bottom: 4px; } #fwuqzqmroe .gt_title { color: #333333; font-size: 125%; font-weight: initial; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; border-bottom-color: #FFFFFF; border-bottom-width: 0; } #fwuqzqmroe .gt_subtitle { color: #333333; font-size: 85%; font-weight: initial; padding-top: 3px; padding-bottom: 5px; padding-left: 5px; padding-right: 5px; border-top-color: #FFFFFF; border-top-width: 0; } #fwuqzqmroe .gt_heading { background-color: #FFFFFF; text-align: center; border-bottom-color: #FFFFFF; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #fwuqzqmroe .gt_bottom_border { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #fwuqzqmroe .gt_col_headings { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; } #fwuqzqmroe .gt_col_heading { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 6px; padding-left: 5px; padding-right: 5px; overflow-x: hidden; } #fwuqzqmroe .gt_column_spanner_outer { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: normal; text-transform: inherit; padding-top: 0; padding-bottom: 0; padding-left: 4px; padding-right: 4px; } #fwuqzqmroe .gt_column_spanner_outer:first-child { padding-left: 0; } #fwuqzqmroe .gt_column_spanner_outer:last-child { padding-right: 0; } #fwuqzqmroe .gt_column_spanner { border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: bottom; padding-top: 5px; padding-bottom: 5px; overflow-x: hidden; display: inline-block; width: 100%; } #fwuqzqmroe .gt_spanner_row { border-bottom-style: hidden; } #fwuqzqmroe .gt_group_heading { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; text-align: left; } #fwuqzqmroe .gt_empty_group_heading { padding: 0.5px; color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; vertical-align: middle; } #fwuqzqmroe .gt_from_md > :first-child { margin-top: 0; } #fwuqzqmroe .gt_from_md > :last-child { margin-bottom: 0; } #fwuqzqmroe .gt_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; margin: 10px; border-top-style: solid; border-top-width: 1px; border-top-color: #D3D3D3; border-left-style: none; border-left-width: 1px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 1px; border-right-color: #D3D3D3; vertical-align: middle; overflow-x: hidden; } #fwuqzqmroe .gt_stub { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; } #fwuqzqmroe .gt_stub_row_group { color: #333333; background-color: #FFFFFF; font-size: 100%; font-weight: initial; text-transform: inherit; border-right-style: solid; border-right-width: 2px; border-right-color: #D3D3D3; padding-left: 5px; padding-right: 5px; vertical-align: top; } #fwuqzqmroe .gt_row_group_first td { border-top-width: 2px; } #fwuqzqmroe .gt_row_group_first th { border-top-width: 2px; } #fwuqzqmroe .gt_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #fwuqzqmroe .gt_first_summary_row { border-top-style: solid; border-top-color: #D3D3D3; } #fwuqzqmroe .gt_first_summary_row.thick { border-top-width: 2px; } #fwuqzqmroe .gt_last_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #fwuqzqmroe .gt_grand_summary_row { color: #333333; background-color: #FFFFFF; text-transform: inherit; padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; } #fwuqzqmroe .gt_first_grand_summary_row { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-top-style: double; border-top-width: 6px; border-top-color: #D3D3D3; } #fwuqzqmroe .gt_last_grand_summary_row_top { padding-top: 8px; padding-bottom: 8px; padding-left: 5px; padding-right: 5px; border-bottom-style: double; border-bottom-width: 6px; border-bottom-color: #D3D3D3; } #fwuqzqmroe .gt_striped { background-color: rgba(128, 128, 128, 0.05); } #fwuqzqmroe .gt_table_body { border-top-style: solid; border-top-width: 2px; border-top-color: #D3D3D3; border-bottom-style: solid; border-bottom-width: 2px; border-bottom-color: #D3D3D3; } #fwuqzqmroe .gt_footnotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #fwuqzqmroe .gt_footnote { margin: 0px; font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #fwuqzqmroe .gt_sourcenotes { color: #333333; background-color: #FFFFFF; border-bottom-style: none; border-bottom-width: 2px; border-bottom-color: #D3D3D3; border-left-style: none; border-left-width: 2px; border-left-color: #D3D3D3; border-right-style: none; border-right-width: 2px; border-right-color: #D3D3D3; } #fwuqzqmroe .gt_sourcenote { font-size: 90%; padding-top: 4px; padding-bottom: 4px; padding-left: 5px; padding-right: 5px; } #fwuqzqmroe .gt_left { text-align: left; } #fwuqzqmroe .gt_center { text-align: center; } #fwuqzqmroe .gt_right { text-align: right; font-variant-numeric: tabular-nums; } #fwuqzqmroe .gt_font_normal { font-weight: normal; } #fwuqzqmroe .gt_font_bold { font-weight: bold; } #fwuqzqmroe .gt_font_italic { font-style: italic; } #fwuqzqmroe .gt_super { font-size: 65%; } #fwuqzqmroe .gt_footnote_marks { font-size: 75%; vertical-align: 0.4em; position: initial; } #fwuqzqmroe .gt_asterisk { font-size: 100%; vertical-align: 0; } #fwuqzqmroe .gt_indent_1 { text-indent: 5px; } #fwuqzqmroe .gt_indent_2 { text-indent: 10px; } #fwuqzqmroe .gt_indent_3 { text-indent: 15px; } #fwuqzqmroe .gt_indent_4 { text-indent: 20px; } #fwuqzqmroe .gt_indent_5 { text-indent: 25px; } Characteristic HR1 95% CI1 p-value age 1.02 1.01, 1.04 0.002 sex     F — —     M 0.77 0.56, 1.05 0.10 donor_match     haplo — —     haplo/MMUD 1.78 0.57, 5.59 0.3     MMRD 0.00 0.00, 0.00     MMUD 1.52 0.65, 3.58 0.3     MRD 0.58 0.26, 1.28 0.2     MUD 0.74 0.35, 1.59 0.4 graft     BM — —     CD34 1.28 0.59, 2.79 0.5     PBSC 1.64 0.85, 3.16 0.14     UCB 0.88 0.36, 2.19 0.8 intensity     Ablative — —     Nonablative 0.95 0.53, 1.71 0.9     Reduced Intensity 1.25 0.75, 2.09 0.4 ursodiol2     N — —     Y 0.66 0.46, 0.94 0.022 1 HR = Hazard Ratio, CI = Confidence Interval "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
